Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Kopran Ltd.

NSE: KOPRAN | BSE:524280

₹252.45 -0.15 (-0.06%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

251.70

Today’s High

256.50

52W low

159.70

52W High

292.30

Open Price

252.80

Prev. Close

236.5500

Volume

182396.00

Value

46045870.20

Fundamentals

Market Cap Cr

1217.10

Price to Earnings

23.90

Price to Book Value

2.50

Dividend Yield

1.20

PE to Growth

0.30

Op Revenue TTM Cr

614.59

Net Profit TTM Cr

50.96

Cash From Operating Activity Cr

43.22

Return on Equity %

10.37

EMA & SMA

Bullish Moving Averages

9

Bearish Moving Averages

7

5Day EMA

253.3

10Day EMA

253.1

12Day EMA

252.7

20Day EMA

250.6

26Day EMA

249.6

50Day EMA

249

100Day EMA

249.2

200Day EMA

240.3

5Day SMA

253.5

10Day SMA

254.4

20Day SMA

251

30Day SMA

243.8

50Day SMA

245.8

100Day SMA

252.8

150Day SMA

255.2

200Day SMA

248.5

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

04 Jul, 2024

52.6

Week

51

Month

44.6

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

253.55

PIVOT

First Resistance

255.40

Second Resistance

258.35

Third Resistance

260.20

First Support

250.60

Second Support

248.75

Third Support

245.80

Relative Strength Index

53.18

Money Flow Index

54.38

MACD

3.07

MACD Signal

3.14

Average True Range

8.65

Average Directional Index

15.06

Rate of Change (21)

20.7

Rate of Change (125)

0.32

Commodity Channel Index

19.7

Williams %R

-84.2

BETA

1 Month

1.66

3 Month

1.33

1 Year

1.02

3 Year

0.51

PRICE CHANGE ANALYSIS

↓ -2.35%

1 Week

Low

High

250

262

↑ 11.56%

1 Month

Low

High

198.05

265.5

↓ -5.75%

3 Months

Low

High

198.05

292.2

↓ -7.68%

6 Months

Low

High

198.05

292.3

↑ 34.57%

1 Year

Low

High

159.7

292.3

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 98.77 83.62 104.43 66.04 82.30 69.12 68.36 70.29 66.63 56.15 58.20
Operating Expenses Qtr 75.28 70.27 89.94 63.74 72.86 61.86 47.72 63.63 57.67 51.12 51.62
Operating Profit Qtr 15.34 12.06 8.70 2.12 7.36 6.10 5.90 6.48 6.68 3.45 4.60
EBIDT Qtr Cr 23.49 13.35 14.49 2.30 9.44 7.26 20.64 6.66 8.96 5.03 6.57
Depreciation Qtr 1.16 1.17 1.16 1.12 1.09 1.12 1.12 1.08 1.06 1.10 1.09
Net Profit Qtr 15.31 8.51 10.66 0.15 5.52 4.04 17.89 3.80 4.77 2.32 3.78
Basic EPS Qtr 3.18 1.77 2.21 0.03 1.14 0.84 3.71 0.79 1.08 0.54 0.87
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 354.17 289.18 212.55 233.25 181.28
Operating Expenses Annual Cr 300.53 245.18 189.11 192.63 156.11
Operating Profit Annual 36.93 27.91 15.41 30.20 23.18
Operating Profit Margin Annual % 10.43 9.65 7.25 12.95 12.78
Total Expenses Annual Cr 309.65 252.27 196.38 200.54 165.55
EBIDT Annual Cr 53.64 44.00 23.44 40.61 25.17
EBIDT Annual margin % 15.14 15.22 11.03 17.41 13.88
Depreciation 4.62 4.41 4.32 4.10 3.47
PAT Before ExtraOrdinary Items Annual Cr 34.64 31.25 11.74 23.47 11.22
Net Profit Annual 34.64 31.25 11.74 23.47 11.22
Basic EPS Annual 7.18 6.48 2.65 5.43 2.59
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 416.87 395.59 378.72 246.85 229.67
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 9.47 9.48 9.14 8.53 13.55
Total Current Liabilities Annual Cr 84.54 100.88 76.25 68.57 83.87
Total Capital Plus Liabilities Annual Cr 510.88 505.95 464.12 323.95 327.09
Fixed Assets Annual 56.72 50.88 49.32 50.26 50.02
Total Non Current Assets Annual 323.17 315.54 312.81 212.84 212.86
Total Current Assets Annual 187.70 190.41 151.31 111.12 114.23
Total Assets Annual 510.88 505.95 464.12 323.95 327.09
Contingent Liabilities plus Commitments Annual Cr - 48.11 45.45 54.96 86.32
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 34.96 16.87 -37.81 48.77 9.97
Cash from Investing Activity Annual -6.27 10.05 -100.26 -8.51 0.63
Cash from Financing Annual Activity -24.08 -26.13 138.00 -40.14 -10.60
Net Cash Flow Annual - 0.79 -0.07 0.12 0.00
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 86.47 82.05 78.56 57.07 53.10
ROE Annual % 8.30 7.90 3.10 9.50 4.88
ROCE Annual % 11.49 9.77 4.92 14.29 8.91
Total Debt to Total Equity Annual 0.05 0.07 0.10 0.06 0.16
EBDIT Annual Margin % 15.89 16.11 11.46 18.22 14.03
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 195.75 161.35 152.72 119.39 152.66 160.22 117.40 122.34 143.92 135.97 130.08
Operating Expenses Qtr 164.39 135.34 129.76 110.69 136.72 145.68 106.83 108.54 115.86 104.68 103.55
Operating Profit Qtr 21.69 23.58 22.83 6.31 12.16 12.32 10.14 13.15 26.00 27.13 24.02
EBIDT Qtr Cr 31.36 26.01 22.96 8.70 15.94 14.54 10.58 13.80 28.06 31.30 26.53
Depreciation Qtr 3.59 3.27 2.77 3.26 3.24 3.16 3.25 3.05 2.69 2.88 2.83
Net Profit Qtr 18.62 15.79 13.77 2.77 8.04 6.95 4.65 7.60 17.51 20.07 17.09
Basic EPS Qtr 3.86 3.28 2.86 0.58 1.67 1.44 0.97 1.58 3.68 4.64 3.95
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 629.20 554.05 488.13 509.80 360.13
Operating Expenses Annual Cr 540.18 499.19 390.13 410.03 312.80
Operating Profit Annual 74.41 51.80 87.39 81.78 46.70
Operating Profit Margin Annual % 11.83 9.35 17.90 16.04 12.97
Total Expenses Annual Cr 561.66 517.99 406.35 426.46 331.29
EBIDT Annual Cr 89.02 54.86 98.00 99.77 47.33
EBIDT Annual margin % 14.15 9.90 20.08 19.57 13.14
Depreciation 12.89 12.71 11.10 10.19 9.58
PAT Before ExtraOrdinary Items Annual Cr 50.96 27.23 61.03 61.61 21.02
Net Profit Annual 50.96 27.23 61.03 61.61 21.02
Basic EPS Annual 10.57 5.65 13.77 14.24 4.86
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 491.25 439.25 426.17 245.03 189.68
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 33.47 33.48 33.13 33.67 41.71
Total Current Liabilities Annual Cr 218.53 176.97 151.59 160.68 140.05
Total Capital Plus Liabilities Annual Cr 743.25 649.70 610.89 439.38 371.45
Fixed Assets Annual 278.29 234.57 186.23 155.08 141.39
Total Non Current Assets Annual 289.22 250.63 196.01 162.43 148.85
Total Current Assets Annual 454.03 399.07 414.87 276.95 222.60
Total Assets Annual 743.25 649.70 610.89 439.38 371.45
Contingent Liabilities plus Commitments Annual Cr - 19.87 47.91 23.08 123.44
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 43.22 34.02 -33.48 59.95 31.00
Cash from Investing Activity Annual -43.55 -12.65 -84.42 -24.41 -12.52
Cash from Financing Annual Activity 0.99 -19.84 122.82 -34.57 -18.06
Net Cash Flow Annual - 1.53 4.93 0.97 0.42
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 101.89 91.11 88.40 56.65 43.86
ROE Annual % 10.37 6.19 14.32 25.14 11.08
ROCE Annual % 14.51 8.91 18.91 32.14 16.31
Total Debt to Total Equity Annual 0.20 0.17 0.17 0.26 0.41
EBDIT Annual Margin % 14.48 9.95 20.52 20.28 13.16
Name Holding Percent Holding Id Pledged % Locked %
MADHURI MADHUSUDAN KELA 1.04 74200474 - -
Name Holding Percent Holding Id Pledged % Locked %
RAJENDRA SOMANI 3.66 74200437 0 0
SUSHEEL SOMANI 1.81 74200438 0 0
MRIDULA SOMANI 1.64 74200439 0 0
SURENDRA SOMANI 1.24 74200440 0 0
VANDANA SOMANI 0.67 74200441 0 0
VARUN SOMANI 0.57 74200442 0 0
NUPUR SOMANI 0.56 74200443 0 0
JAYA SOMANI 0.54 74200444 0 0
Oricon Enterprises Ltd 12.9 74200451 0 3.22
Panorama Finvest Pvt Ltd 7.88 74200452 0 0
Sarvamangal Mercantile Co. Ltd. 6.02 74200453 0 0
UNITED SHIPPERS LTD 4.56 74200454 0 100
PARIJAT SHIPPING AND FINALE LTD. 0.8 74200455 0 0
G.CLARIDGE & COMPANY LIMITED 0.71 74200456 0 0
Name Holding Percent Holding Id
Name Holding Percent Holding Id
MADHURI MADHUSUDAN KELA 1.04 74200474
HUF 2.17 74200467
Clearing Members 1.02 74200468
LAXMINARAYAN VYAPAAR P LTD 1.95 74200471
VIRAJ RUSSELL MEHTA 1.85 74200476
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Sep 07, 2023 3 FINAL - Equity Share
Aug 04, 2022 3 FINAL - Equity Share
Aug 05, 2021 1.5 FINAL - Equity Share
Nov 05, 2020 1.5 INTERIM Nov 07, 2020 Equity Share
Sep 12, 2002 - FINAL - Equity Share
Sep 03, 2001 - FINAL - Equity Share
Sep 11, 2000 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 16, 2024 Audited Results & Final Dividend -
Feb 07, 2024 Quarterly Results -
Nov 07, 2023 Quarterly Results -
Aug 10, 2023 Quarterly Results -
May 25, 2023 Audited Results & Dividend -
Feb 10, 2023 Quarterly Results -
Nov 11, 2022 Quarterly Results -
Aug 10, 2022 Quarterly Results -
May 27, 2022 Audited Results & Final Dividend -
Feb 03, 2022 Quarterly Results -
Oct 27, 2021 Quarterly Results -
Aug 06, 2021 Quarterly Results -
May 27, 2021 Audited Results & Final Dividend -
Jan 22, 2021 Quarterly Results -
Oct 28, 2020 Quarterly Results & Interim Dividend -
Aug 11, 2020 Quarterly Results -
Jun 30, 2020 Audited Results -
Feb 01, 2020 Quarterly Results -
Jan 31, 2020 Quarterly Results -
Oct 24, 2019 Quarterly Results -
Aug 08, 2019 Quarterly Results -
May 08, 2019 Audited Results -
Jan 21, 2019 Quarterly Results -
Nov 05, 2018 Quarterly Results -
Aug 08, 2018 Quarterly Results -
May 29, 2018 Audited Results -
Feb 13, 2018 Quarterly Results -
Dec 14, 2017 Quarterly Results -
Sep 13, 2017 Quarterly Results -
May 24, 2017 Audited Results -
Feb 07, 2017 Quarterly Results -
Nov 14, 2016 Quarterly Results 1. Re-appointment of Mr. Surendra Somani, Executive Vice Chairman 2. Mr. Surendra Somani,Executive Vice Chairman, Mr. Ajit Jain, Chief Operating Officer and Mr. Sunil Sodhani, Company Secretary.
Aug 09, 2016 Quarterly Results -
May 30, 2016 Audited Results -
Feb 11, 2016 Quarterly Results -
Nov 06, 2015 Quarterly Results -
Aug 12, 2015 Quarterly Results -
Jul 14, 2015 Others Sale of Consumer Care Division of the Company.
May 28, 2015 Audited Results -
Feb 13, 2015 Quarterly Results -
Nov 12, 2014 Quarterly Results -
Sep 29, 2014 Others (1) To consider issue of Equity Shares and/ or Warrants on Preferential basis to Promoter Group. (2) To consider Slump Sales of (API) business to its Subsidiary Co. Kopran Research Laboratories Ltd.
Aug 14, 2014 Quarterly Results -
May 28, 2014 Audited Results -
Feb 13, 2014 Quarterly Results -
Nov 13, 2013 Quarterly Results -
Aug 10, 2013 Quarterly Results -
May 29, 2013 Audited Results -
Feb 12, 2013 Quarterly Results -
Nov 10, 2012 Quarterly Results -
Aug 14, 2012 Quarterly Results -
Jul 13, 2012 Audited Results (Revised)
May 15, 2012 Quarterly Results -
Feb 11, 2012 Quarterly Results -
Nov 12, 2011 Quarterly Results -
Jul 29, 2011 Audited & Quarterly Results -
May 14, 2011 Quarterly Results -
Feb 11, 2011 Quarterly Results -
Nov 15, 2010 Quarterly Results -
Aug 10, 2010 Audited, Quarterly Results & Others The Board has allotted 19,50,000 Equity Shares of Rs. 10/- each for cash at par, (i.e. at a price determined as per SEBI Guidelines) against 19,50,000 CW's held by Panorama Finvest Pvt. Ltd.
May 14, 2010 Quarterly Results -
Jan 29, 2010 Quarterly Results -
Oct 31, 2009 Quarterly Results -
Jul 29, 2009 Quarterly Results -
Jun 30, 2009 Audited Results & Others To issue on Preferential basis 19,50,000 Warrants and 18,50,000 equity shares of Rs 10 each, to the Promoters / Associates at a price arrived at as per SEBI Guidelines.
Jan 30, 2009 Quarterly Results -
Oct 25, 2008 Quarterly Results -
Oct 11, 2008 Others To divest its stake in the Joint Ventures namely, Globalpharma LLC, Dubai and Kampala Pharmaceutical Industries, Uganda.
Jul 30, 2008 Quarterly Results -
Jun 30, 2008 Audited Results -
Jan 31, 2008 Quarterly Results (Revised)
Jan 08, 2008 Audited Results -
Jan 03, 2008 Audited Results (18 months) -
Sep 21, 2007 Quarterly Results -
Jun 30, 2007 Audited Results -
Apr 30, 2007 Quarterly Results -
Jan 31, 2007 Quarterly Results -
Oct 30, 2006 Quarterly Results -
Aug 24, 2006 Preferential Allotment of shares To consider Preferential Allotment of Equity Shares pursuant to Section 81(1A) of the Companies Act, 1956 to Banks and Financial Institutions.
Jul 31, 2006 Accounts & Quarterly Results -
Apr 27, 2006 Quarterly Results -
Apr 21, 2006 Allotment of equity shares & Warrants a. 47,20,000 Equity Shares of Rs 10/- each, at a price of Rs 54.70/- per Equity Share b. 58,42,000 Warrants with an option to subscribe into equal number of Equity Shares.
Mar 11, 2006 Further issue of Equity Shares Inter alia, to consider, a proposal of further issue of Equity Shares in one or more trenches, by way of private placement / preferential allotment.
Jan 31, 2006 Quarterly Results -
Oct 24, 2005 Quarterly Results -
Jun 03, 2005 Issue and allotment of Warrants Issue and allotment of 12150000 warrants to Clear Water Capital Partner(Cyprus) Ltd.
Apr 25, 2005 Unaudited Financial Results -
Mar 11, 2005 Issue of equity shares To consider a proposal to further issue of equity in one or more trenches, by way of private placement / preferential allotment of equity shares.
Jan 29, 2005 Quarterly Results & Others to finalize the effective date and to consider & approve allotment of Eq. Shares by the Co. to the shareholders of Kopran Pharmaceuticals in view of Order passed by the Hon'ble High Court of Bombay.
Oct 29, 2004 Quarterly Results -
Jul 31, 2004 Quarterly Results & Accounts -
Apr 29, 2004 Quarterly Results -
Jan 30, 2004 Quarterly Results -
Oct 31, 2003 Quarterly Results -
Sep 25, 2003 Accounts -
Jul 31, 2003 Quarterly Results (Revised)
Apr 29, 2003 Quarterly Results -
Jan 31, 2003 Quarterly Results -
Oct 29, 2002 Quarterly Results -
Jun 25, 2002 Accounts & Dividend -
Jan 31, 2002 Quarterly Results -
Dec 22, 2001 Right Issue of Equity Shares -
Oct 31, 2001 Quarterly Results -
Aug 04, 2001 Accounts (Cancelled)
Jul 31, 2001 Quarterly Results -
Jun 30, 2001 Accounts & Dividend -
Jan 30, 2001 Quarterly Results -
Dec 21, 2000 Others To consider business process reengineering initiated by KPMG and being implemented by Rabo India Finance Pvt. Ltd., including the decision regarding merger of Kopran Pharma Ltd.with the Company
Oct 24, 2000 Quarterly Results Revised
Sep 04, 2000 Accounts & Dividend -
Jul 31, 2000 Quarterly Results -
Apr 29, 2000 Quarterly Results -
Feb 21, 2000 Others Issue of Eq.Shares to members etc., public/rights issue, preferential offer
Jan 29, 2000 Quarterly Results -
Dec 01, 1999 Accounts & Dividend -
Oct 29, 1999 Quarterly Results -
Jul 29, 1999 Quarterly Results -
Apr 29, 1999 Quarterly Results -
Jan 30, 1999 Quarterly Results -
Oct 31, 1998 Quarterly Results -
Jul 28, 1998 Half Yearly Results -
Nov 27, 1997 Half Yearly Results -
Aug 26, 1997 Accounts & Dividend -
May 19, 1997 Half Yearly Results. -
Ex-Date Bonus Ratio Record Date
Bigul
28 Jun 2024

KOPRAN LTD. - 524280 - Closure of Trading Window

 Closure of Trading Window for the Period ended June 30,2024
Bigul
12 Jun 2024

KOPRAN LTD. - 524280 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of Loss of Share Certificate
Bigul
23 May 2024

KOPRAN LTD. - 524280 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Annual Secretarial Compliance Report for the year ended March 31, 2024
Bigul
18 May 2024

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Transcript of Investors Meet held on May 17, 2024
Bigul
18 May 2024

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication
Bigul
16 May 2024

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Investor Presentation on Audited Financial Results for the quarter and year ended March 31, 2024
Bigul
16 May 2024

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Change in Management

 Re-appointment of Directors
Bigul
16 May 2024

KOPRAN LTD. - 524280 - Board Meeting Outcome for Dividend & Annual General Meeting Date

 Dividend & Annual General Meeting Date
Bigul
16 May 2024

KOPRAN LTD. - 524280 - Results-Financial Results For March 31, 2024

 Statement of Audited Standalone & Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024
Bigul
14 May 2024

KOPRAN LTD. - 524280 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Conference call on Q4 FY24 Results
See all News

FAQs

The latest market price of Kopran Ltd. on NSE was Rs. 252.45 as of today.

The opening share price of Kopran Ltd. was Rs. 252.80 as of today.

The 52-week high share price of Kopran Ltd. was Rs. 292.30.

The 52 week low share price of Kopran Ltd. was Rs. 159.70.

Kopran Ltd. has a market cap of Rs. 1217.10 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Kopran Ltd. is 0.30. Please refer to the Fundamentals section for further details.

The operating revenue for Kopran Ltd. in the last FY was Rs.  614.59 crore. Please refer to the Financials section for further details.

The Net Profit for Kopran Ltd. in the last FY was Rs. 50.96 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Kopran Ltd. was on 2023-09-07 for Rs. 3 per share. According to today’s share price, the dividend yield of Kopran Ltd. stands at 1.20. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Kopran Ltd..

Close

Let's Open Free Demat Account